Suite à leur accord de 250 millions de dollars (231 M€) noué en avril dernier, le laboratoire britannique GlaxoSmithKline (GSK) et la biotech américaine Vir Biotechnology ont annoncé le ...
Vir Biotechnology, Inc. (NASDAQ:VIR – Free Report) – Equities researchers at HC Wainwright issued their Q1 2026 earnings estimates for shares of Vir Biotechnology in a research note issued on ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback